Global NF1 severity and visibility scores reported in this study were similar to previous studies of non‐clinical (Page et al., 2006) and clinical cohorts of individuals with NF1 (Kodra et al., 2009; Wolkenstein et al., 2001); with severe and more visible disease associated with increased age. This evidence concerns the gene NF1 and neurofibromatosis type 1.